Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention
- PMID: 31239092
- DOI: 10.1016/j.idc.2019.04.002
Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention
Abstract
Preventing new human immunodeficiency virus (HIV) infections is essential to halting the global pandemic. HIV prevention strategies include integrating both nonpharmacologic (eg, safe sexual counseling, circumcision) and pharmacologic approaches. Several pharmacologic HIV prevention strategies are increasingly used globally and include postexposure prophylaxis, preexposure prophylaxis, and treatment as prevention. These prevention modalities have enormous clinical and public health appeal, as they effectively reduce HIV acquisition in individuals and also may lower HIV incidence in communities when integrated and implemented broadly. Efforts are now underway to scale HIV prevention programs using these techniques in both high- and low-resource settings.
Keywords: HIV; PEP; Postexposure prophylaxis; PrEP; Preexposure prophylaxis; Prevention; Treatment as prevention.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Antiretroviral Therapy for Prevention of Human Immunodeficiency Virus Infection.Med Clin North Am. 2016 Jul;100(4):927-50. doi: 10.1016/j.mcna.2016.03.013. Med Clin North Am. 2016. PMID: 27235622 Review.
-
Laboratory Testing of a Cohort of Commercially Insured Users of HIV Preexposure Prophylaxis in the United States, 2011-2015.J Infect Dis. 2018 Jan 30;217(4):617-621. doi: 10.1093/infdis/jix595. J Infect Dis. 2018. PMID: 29145597
-
Update on HIV Chemoprevention.Annu Rev Med. 2025 Jan;76(1):43-56. doi: 10.1146/annurev-med-042823-013707. Annu Rev Med. 2025. PMID: 39869431 Review.
-
The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.Clin Infect Dis. 2015 Jun 1;60 Suppl 3(Suppl 3):S200-4. doi: 10.1093/cid/civ094. Clin Infect Dis. 2015. PMID: 25972505 Free PMC article.
-
Prevention Strategies Against HIV Transmission: A Proactive Approach.J Pharm Pract. 2018 Feb;31(1):82-90. doi: 10.1177/0897190017696946. Epub 2017 Mar 21. J Pharm Pract. 2018. PMID: 29278971 Review.
Cited by
-
Perception and barriers to access Pre-exposure Prophylaxis for HIV/AIDS (PrEP) among the MSM (men who have sex with men) Brazilian Amazon: A qualitative study.PLoS One. 2024 Sep 26;19(9):e0296201. doi: 10.1371/journal.pone.0296201. eCollection 2024. PLoS One. 2024. PMID: 39325811 Free PMC article.
-
The Effect of Antiretroviral Therapy on SIRT1, SIRT3 and SIRT6 Expression in HIV-Infected Patients.Molecules. 2022 Feb 17;27(4):1358. doi: 10.3390/molecules27041358. Molecules. 2022. PMID: 35209148 Free PMC article.
-
Adherence, adverse drug reactions, and discontinuation associated with adverse drug reactions of HIV post-exposure prophylaxis: a meta-analysis based on cohort studies.Ann Med. 2023;55(2):2288309. doi: 10.1080/07853890.2023.2288309. Epub 2023 Dec 8. Ann Med. 2023. PMID: 38065681 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous